What is DermaVogue?
DermaVogue, based in Garden City, is a prominent provider of advanced cosmetic dermatology services. The company specializes in a comprehensive suite of treatments, including popular procedures like Botox, Juvaderm, fillers, and a variety of advanced skin rejuvenation therapies. Led by the experienced Dr. James E. Turek MD, DermaVogue has built a reputation over two decades for delivering exceptional service, expert care, and highly personalized treatment plans designed to achieve optimal aesthetic outcomes for its clientele. Their offerings extend to facial enhancements, body contouring, and a curated selection of professional skincare products tailored to individual client needs.
How much funding has DermaVogue raised?
DermaVogue has raised a total of $443K across 1 funding round:
Debt
$443K
Debt (2025): $443K, investors not publicly disclosed
What's next for DermaVogue?
The substantial large-scale late-stage funding positions DermaVogue for significant strategic advancements. This capital infusion is expected to fuel further service innovation, potentially expanding their treatment portfolio or enhancing existing technologies. Furthermore, the 'major strategic investment' context suggests potential collaborations or acquisitions aimed at solidifying market leadership and broadening their geographic reach. DermaVogue is poised to leverage this financial backing to reinforce its commitment to client satisfaction and maintain its standing as a leader in cosmetic dermatology.
See full DermaVogue company page
